•
Jun 30, 2021

CME Group Q2 2021 Earnings Report

CME Group's financial performance reflected growth in trading volume and strategic product innovation.

Key Takeaways

CME Group reported a revenue of $1.2 billion and an operating income of $675 million for Q2 2021. The average daily volume grew by 5%, driven by increases in Interest Rates, Agricultural, and Options markets. The company also introduced innovative new products, including micro-sized contracts and ESG-focused futures contracts.

Revenue reached $1.2 billion, and operating income was $675 million.

Average daily volume increased by 5% year-over-year.

Growth was driven by double-digit increases in Interest Rates, Agricultural, and Options markets.

Introduced new micro-sized contracts and ESG-focused futures contracts.

Total Revenue
$1.18B
Previous year: $1.18B
-0.3%
EPS
$1.64
Previous year: $1.63
+0.6%
Average Daily Volume
18.44M
Previous year: 17.6M
+4.8%
Average Rate Per Contract
$0.695
Previous year: $0.731
-4.9%
Gross Profit
$968M
Previous year: $965M
+0.2%
Cash and Equivalents
$1.08B
Previous year: $1.41B
-23.1%
Free Cash Flow
$460M
Previous year: $950M
-51.6%
Total Assets
$179B
Previous year: $117B
+52.5%

CME Group

CME Group

CME Group Revenue by Segment

Forward Guidance

CME Group will continue to support clients’ evolving trading needs through additional product innovation and the upcoming launch of our joint venture company to provide post-trade services for OTC markets.

Revenue & Expenses

Visualization of income flow from segment revenue to net income